TRAF6 maintains mammary stem cells and promotes pregnancy-induced mammary epithelial cell expansion.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
2019
Historique:
received: 27 09 2018
accepted: 15 07 2019
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 10 8 2019
Statut: epublish

Résumé

Receptor activator of nuclear factor (NF)-κB (RANK) signaling promotes pregnancy-dependent epithelial cell differentiation and expansion for mammary gland development, which requires NF-κB pathway-dependent Cyclin D1 induction and inhibitor of DNA binding 2 (Id2) pathway-dependent anti-apoptotic gene induction. However, the roles of tumor necrosis factor receptor-associated factor 6 (TRAF6) remain unclear despite its requirement in RANK signaling. Here we show that TRAF6 is crucial for both mammary stem cell maintenance and pregnancy-induced epithelial cell expansion. TRAF6 deficiency impairs phosphoinositide 3-kinase (PI3K)/AKT and canonical NF-κB pathways, whereas noncanonical NF-κB signaling remains functional. Therefore, we propose that TRAF6 promotes cell proliferation by activating PI3K/AKT signaling to induce retinoblastoma phosphorylation in concert with noncanonical NF-κB pathway-dependent Cyclin D1 induction. Furthermore, TRAF6 inhibits apoptosis by activating canonical NF-κB signaling to induce anti-apoptotic genes with the Id2 pathway. Therefore, proper orchestration of TRAF6-dependent and -independent RANK signals likely establishes mammary gland formation.

Identifiants

pubmed: 31396572
doi: 10.1038/s42003-019-0547-7
pii: 547
pmc: PMC6684589
doi:

Substances chimiques

Ccnd1 protein, mouse 0
NF-kappa B 0
Receptor Activator of Nuclear Factor-kappa B 0
Retinoblastoma Protein 0
TNF Receptor-Associated Factor 6 0
TRAF6 protein, mouse 0
Tnfrsf11a protein, mouse 0
Cyclin D1 136601-57-5
Phosphatidylinositol 3-Kinase EC 2.7.1.137
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

292

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing interests.

Références

PLoS One. 2011 Apr 29;6(4):e19234
pubmed: 21559440
Horm Cancer. 2010 Jun;1(3):127-35
pubmed: 21152357
Mol Cell Biol. 2006 Feb;26(3):1002-13
pubmed: 16428453
Nature. 2010 Jun 10;465(7299):798-802
pubmed: 20383121
Nature. 2015 Jan 1;517(7532):81-4
pubmed: 25327250
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3074-9
pubmed: 24569806
Nat Cell Biol. 2008 Jun;10(6):716-22
pubmed: 18469806
Wiley Interdiscip Rev Syst Biol Med. 2016 May;8(3):227-41
pubmed: 26990581
Nature. 2010 Nov 4;468(7320):98-102
pubmed: 20881962
Sci Signal. 2009 Oct 20;2(93):ra66
pubmed: 19843958
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1783-1788
pubmed: 29432170
J Natl Cancer Inst. 1974 Apr;52(4):1375-8
pubmed: 4363715
Adv Exp Med Biol. 2007;597:72-9
pubmed: 17633018
Cell. 2001 Dec 14;107(6):763-75
pubmed: 11747812
Mol Cell Biol. 2011 Dec;31(23):4775-88
pubmed: 21947283
Cancer Sci. 2009 Sep;100(9):1668-74
pubmed: 19538528
Curr Opin Cell Biol. 2004 Apr;16(2):119-26
pubmed: 15196553
Nat Med. 2016 Aug;22(8):933-9
pubmed: 27322743
Cancer Cell. 2009 May 5;15(5):389-401
pubmed: 19411068
Cell. 2000 Sep 29;103(1):41-50
pubmed: 11051546
Nature. 2006 Mar 30;440(7084):692-6
pubmed: 16572175
Cancer Res. 2015 Jan 1;75(1):62-72
pubmed: 25398440
Nat Med. 2007 Jan;13(1):62-9
pubmed: 17159986
Cell Death Differ. 2008 Apr;15(4):730-8
pubmed: 18202703
EMBO J. 2015 Mar 4;34(5):641-52
pubmed: 25603931
Dev Biol. 1999 Jul 15;211(2):238-54
pubmed: 10395785
Nature. 2010 Jun 10;465(7299):803-7
pubmed: 20445538
Nat Cell Biol. 2014 Dec;16(12):1238-48
pubmed: 25362351
Genes Dev. 2009 Nov 15;23(22):2563-77
pubmed: 19933147
Wiley Interdiscip Rev Dev Biol. 2012 Jul-Aug;1(4):533-57
pubmed: 22844349
Breast Cancer Res. 2004;6(3):105-8
pubmed: 15084230
Cell Res. 2011 Jan;21(1):71-85
pubmed: 21173796
J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):25-35
pubmed: 17431797
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8766-71
pubmed: 12060722
J Clin Invest. 2011 Oct;121(10):4095-105
pubmed: 21911935
Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):181-95
pubmed: 25645332
Bioorg Med Chem Lett. 2005 Feb 15;15(4):905-9
pubmed: 15686884
Science. 2005 Apr 8;308(5719):248-51
pubmed: 15705807
Front Immunol. 2012 Sep 04;3:278
pubmed: 22969770
Genes Dev. 2014 Jun 1;28(11):1143-58
pubmed: 24888586
J Mammary Gland Biol Neoplasia. 2005 Jul;10(3):211-9
pubmed: 16807801
Bioorg Med Chem Lett. 2005 Feb 1;15(3):761-4
pubmed: 15664853
Nat Immunol. 2011 Jul 19;12(8):695-708
pubmed: 21772278
Trends Endocrinol Metab. 2011 May;22(5):188-94
pubmed: 21470874
Oncogene. 2007 Jul 12;26(32):4656-67
pubmed: 17297453
Nat Commun. 2013;4:2299
pubmed: 23934482
Mol Biol Cell. 2004 May;15(5):2302-11
pubmed: 15105443
Cancer Res. 1959 Jun;19(5):515-20
pubmed: 13663040
Development. 2015 Mar 15;142(6):1028-42
pubmed: 25758218
Science. 2016 Jan 1;351(6268):84-8
pubmed: 26628643
J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):119-23
pubmed: 22678420
Genes Cells. 1999 Jun;4(6):353-62
pubmed: 10421844
J Pharmacol Exp Ther. 2005 Jan;312(1):373-81
pubmed: 15316093
Nat Rev Immunol. 2009 Nov;9(11):778-88
pubmed: 19855404
Genes Dev. 2003 May 15;17(10):1253-70
pubmed: 12756227
EMBO J. 2005 Feb 23;24(4):790-9
pubmed: 15678102
Mol Cancer Res. 2005 Jan;3(1):42-9
pubmed: 15671248
Immunol Rev. 2015 Jul;266(1):72-92
pubmed: 26085208
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
Breast Cancer Res Treat. 2018 Jun;169(3):397-406
pubmed: 29417298
Cell Res. 2011 Jan;21(1):86-102
pubmed: 21102550
Mol Cell Biochem. 2012 Dec;371(1-2):177-86
pubmed: 22886393

Auteurs

Mizuki Yamamoto (M)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.
2Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Chiho Abe (C)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Sakura Wakinaga (S)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Kota Sakane (K)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Yo Yumiketa (Y)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Yuu Taguchi (Y)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Takayuki Matsumura (T)

3Department of Immunology, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640 Japan.

Kosuke Ishikawa (K)

4Department of Life Science and Medical Bio-Science, Waseda University, Shinjuku-ku, Tokyo 162-8480 Japan.

Jiro Fujimoto (J)

4Department of Life Science and Medical Bio-Science, Waseda University, Shinjuku-ku, Tokyo 162-8480 Japan.

Kentaro Semba (K)

4Department of Life Science and Medical Bio-Science, Waseda University, Shinjuku-ku, Tokyo 162-8480 Japan.

Maki Miyauchi (M)

Laboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Kanagawa 230-0045 Japan.

Taishin Akiyama (T)

Laboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Kanagawa 230-0045 Japan.

Jun-Ichiro Inoue (JI)

1Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.
2Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Shirokane-dai, Minato-ku, Tokyo 108-8639 Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH